ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 65 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q4 2017. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $90,180 | -53.3% | 60,120 | -50.5% | 0.02% | -56.2% |
| Q2 2023 | $193,015 | +121.6% | 121,393 | 0.0% | 0.05% | +108.7% |
| Q1 2023 | $87,088 | +23.8% | 121,393 | 0.0% | 0.02% | +9.5% |
| Q4 2022 | $70,347 | -23.5% | 121,393 | +25.3% | 0.02% | -27.6% |
| Q3 2022 | $92,000 | -42.1% | 96,910 | -27.0% | 0.03% | -35.6% |
| Q2 2022 | $159,000 | +84.9% | 132,769 | +101.9% | 0.04% | +125.0% |
| Q1 2022 | $86,000 | -9.5% | 65,754 | +21.8% | 0.02% | 0.0% |
| Q4 2021 | $95,000 | -4.0% | 54,000 | +18.4% | 0.02% | -9.1% |
| Q3 2021 | $99,000 | +4.2% | 45,603 | +75.4% | 0.02% | -38.9% |
| Q3 2017 | $95,000 | +46.2% | 25,998 | 0.0% | 0.04% | +33.3% |
| Q2 2017 | $65,000 | +1.6% | 25,998 | +9.5% | 0.03% | +3.8% |
| Q1 2017 | $64,000 | – | 23,746 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 178,654 | $652,000 | 0.48% |
| EcoR1 Capital, LLC | 762,947 | $2,785,000 | 0.37% |
| VHCP Management II, LLC | 280,000 | $1,022,000 | 0.28% |
| MANGROVE PARTNERS IM, LLC | 413,838 | $1,511,000 | 0.26% |
| Sessa Capital IM, L.P. | 638,712 | $2,331,000 | 0.26% |
| 683 Capital Management, LLC | 550,000 | $2,008,000 | 0.21% |
| Rhenman & Partners Asset Management AB | 154,006 | $562,000 | 0.07% |
| ELEMENT CAPITAL MANAGEMENT LLC | 35,346 | $129,000 | 0.05% |
| Tekla Capital Management LLC | 300,078 | $1,095,000 | 0.04% |
| Marquette Asset Management, LLC | 25,998 | $95,000 | 0.04% |